# Vitamin D3 For CGD Patients With BCGosis/Itis

> **NCT03984890** · PHASE2,PHASE3 · COMPLETED · sponsor: **Children's Hospital of Fudan University** · enrollment: 50 (actual)

## Conditions studied

- Vitamin D3
- Chronic-granulomatous Disease
- BCG

## Interventions

- **DRUG:** Vitamin D3
- **DRUG:** Traditional treatment of CGD and TB

## Key facts

- **NCT ID:** NCT03984890
- **Lead sponsor:** Children's Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03984890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03984890, "Vitamin D3 For CGD Patients With BCGosis/Itis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03984890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*